OTCM
KTCIY
Market cap12bUSD
, Last price
USD
Name
KT&G Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
KT&G Corporation, a diversified South Korean enterprise that operates alongside its subsidiaries, specializes in a broad array of industries. Its primary business involves the manufacturing and distribution of tobacco products and related materials. Beyond this, the company is a significant provider of health and wellness items, offering red ginseng, various red ginseng-based goods, and other health-focused foods. Its extensive product portfolio also features food and beverage items, along with cosmetic and beauty products. Further diversifying its operations, KT&G offers support services for leaf tobacco cultivation and maintains a presence in the pharmaceutical and medical sectors. This includes the development, production, and supply of pharmaceuticals, encompassing bio-pharmaceuticals, over-the-counter medicines, and a range of medical supplies and equipment. The corporation also holds investments in commercial ventures such as trading, real estate management, property leasing, and housing development. Additionally, it is involved in the development and ongoing management of hotels. Founded in 1987, the company originally operated under the name Korea Tobacco and Ginseng Corporation before officially changing to KT&G Corporation in December 2002. Its corporate headquarters are situated in Daejeon, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||